Siemens AG All rights reserved.
|
|
- Lilian Skinner
- 6 years ago
- Views:
Transcription
1 How to create a PAT data management platform to support Continuous Production 8th Annual PAT and QbD Conference, London, February 16 th, 2011 Jan Verelst
2 Back in time Page 2
3 What caused this disaster? Information : Hidden Critical Knowledge Knowledge Data Information Page 3
4 Oral Solid Dosage today Delay Delay Delay Delay Raw Material 1 to 2 months to release Granulator Blender Dryer Blender Tablet press Coating Page 5
5 PAT: Key Enabler for Continuous Manufacturing and Real Time Product Release Raw Material SIPAT Quality check Right First Time Real time release Blender Dryer Coating Granulator Tablet press In/At line check Page 6
6 PAT Basics Holistic Approach PAT Advanced Control Quality build in by design Right first time monitoring product quality Real-time release Closed loop control Classic control Temp., Speed, Liquid addition, Compression Force, mathematical translation monitoring process data Lab LIMS Analyzer Hold / release Sample feed output Page 7
7 SIPAT functions Page 8
8 SIPAT Collectors Collector = Interface to read data from external systems as input to SIPAT Method Standard available collectors within SIPAT Instrument collectors (dedicated interfaces to range of analytical instruments) collector (OPC DA Client) File collectors (XML, SPC, JCAMP) PAT Collector (results from other SIPAT Method) Databrowse collectors (ODBC, SQL, OLEDB) Page 9
9 Analyzers Standard analyzer connection available with actual productivity pack: Kaiser Raman (Raman RXN1, RXN3, RXN3L, RXN4R and PhAT); Kaizer s Analyser Control V4.2 Thermo Fischer Antaris and Antaris II family (via Result software) PAA Ltd with GranuMet XP (acoustic emission measurement), Version 4 Bruker NIR via OPUS V6.1 software Bruker NIR via OPUS 6.5 embedded DLL Malvern Insitec Laser Diffraction PSD (RT Sizer software) Malvern Morphology G3 Mettler Toledo collector for ReactIR 4000 (FT-IR) via IC4 software Mettler Toledo MonARC (FT-IR) via IC4 software Mettler Toledo Lasentec FBRM (PSD) via IC4 software Zeiss collector MCS 500 serie (photodiode array UV/visible spectrophotometer) Zeiss collector MCS 600 serie (NIR) Brimrose Luminar 5030 and 4030 AOTF-NIR Expo epat 601 (including an Axsun NIR) Dr. Schleuniger tablet tester (Tandem using Dr. Schleuniger Pharmatron - Bruker) ABB FTPA2000 Bruker LancIR via embedded DLL New productivity packs will be released on a frequent basis Page 10
10 SIPAT: data collection in real time Alignment of Collectors Startup off set Measurement duration Measurement rate REFERENCE COLLECTOR NIR Negative Validity Range Positive Validity Range value (e.g. Temp) Start batch Page 12 Aggregation function : Average Last Value Maximum Middle Minimum First Value Nearest to reference
11 SIPAT: data collection in real time Principle LIMS Raw Material Characteristics SCADA + Context data Analytical Data NIR, PSD Data alignment Contextualization Rules separating non-representative data SIPAT Analyzer Page 13
12 SIPAT functions Page 14
13 SIPAT: data monitoring and control in real time Application data (ph, Temp, Pressure, ) Instrument data (NIR, Raman, PSD, ) Meta & context data Raw Material Data / IPC data (Moisture, ) Alignment Real Time Prediction Quantitative prediction Qualitative prediction Other Application data SIPAT brings all data (in-line, at-line, on-line and off-line) in relation for prediction Page 15 Quelle: Siemens IT Solutions and Services
14 SIPAT Data Model Static data Semi-static data Meta-data Manual/automatic entry Info Info Data Data Perform Calculations Make Predictions using Models Basic Calculations Advanced Calculations Collector Collector Data Data SIPAT SIPAT Method Method Calculations Calculations Input from Analytical Instruments /Automation Level Raw Materials Other Systems Previous process step using Collectors Visualizations Visualizations Configure operator screens Using Charting types Page 17
15 SIPAT: data monitoring and control in real time Principle LIMS RTR Raw Material SCADA Characteristics + Context data Analytical Data Data alignment Contextualization Rules separating non-representative data Statistical RT Models e.g. PLS, PCA Chemometrics (SIMCA, Matlab, Unscrambler, PharmaMV, ) engine embedded in SIPAT CQA Critical to Qualty Attribute Aggregation of CQA over process context - Average, - Standard deviation On line Monitoring Out of control detection Deviation tracking NIR, PSD SIPAT APC Analyzer Page 18
16 SIPAT functions Page 19
17 SIPAT: data mining Principle SIPAT External application Meta & context data Analyser Data ( NIR, Raman, PSD, ) Data Predicted data Off- line lab data (RM,process samples, ) Other data - Batch number - Trial number - step - Product - Campaign. optimization Page 20
18 SIPAT: data mining Model creation & process optimization Turning data into knowledge Improved process understanding Base of QbD Model Builder Integrate all relevant PAT data Send to Chemometrics application Umetrics - Simca Camo - Unscrambler Matlab Perceptive Engineering - PharmaMV optimization Page 21
19 SIPAT functions Page 22
20 Reporting Automated or ad hoc Page 23
21 Reporting Table output Page 24
22 Reporting Graphical output Page 25
23 Reporting Graphical output - spectrum Page 26
24 Reporting Graphical output batch comparison Page 27
25 Why SIPAT? Increase process understanding / manage variability Bring all data (in-line, at-line, on-line and off-line) in relation Provide on-line predictions on product/process quality Shift from lab testing towards in process testing SIPAT 1 common interface for all PAT tools Close the gap between R&D and Manufacturing Page 28
26 Project context End-User Product Know-How Specify required machinery to fulfill a specific production operation Equipment must comply with the own specific norms and standards Focus on the optimized functioning of the complete production line Easy integration of the control level into Plant-IT Siemens Industry know How Standard platform Scalable solutions Easy integration GMP supporting functions Cost effective solutions Long term Support (investment protection) Worldwide Product Support End-user Supplier OEM GEA Pharma Systems Know-How Supply specific equipment + instrumentation to handle a specific production operation Focus on equipment specific optimization Equipment automation specification (PLC, HMI, drive, instrumentation,...) Equipment validation Equipment specific 21 CFR Part 11 functionality Worldwide Packaged Unit Support Page 29
27 PAT Instruments NDC - Moisture NIR (J&M LHP) Moisture+ C. uniformity Malvern Particle Size Page 30 At line analyzer Weight, Hardness, Thickness, Assay
28 High Level System Architecture Real Time Release reporting SITE MES LIMS Supervisory & Control Alarm handling (6) Line Control Analyzers Multivariate Data handling Line Recipe handling Trending Univariate Data Deviation Tracking Critical Parameters SCADA (2) (5) SIPAT (4) PLC / Motion Control ANALYZERS (1) (3) On-line monitoring of the Critical to Quality Attributes (CQA) Deviation Tracking CQA Out of Control Detection & input to APC PROCESS Page 31
29 Traditional PAT in solid dosage Content Uniformity Bulk Physical control parameters Dispense & Blend API Excipients control parameters Wet Granulation Liquid addition control parameters Drying Moisture control parameters Milling Blending Lubrication Lubricant excipient Particle size control parameters Compression Defects Sampling & Off-line analysis control parameters Coating Bulk Physical Defects Test against specifications control parameters Packaging Coating solution Page 32
30 End product quality predictions Input material characteristics Content Assay Uniformity Dissolution control Moisture Disintegration parameters Dispense & Blend Api Excipients control parameters Wet Granulation Liquid addition control parameters Drying (NIR) control parameters Blending / Lubrication Lubricant excipient Particle size (Malvern) control parameters Compression Weight Hardness Thickness control parameters Coating Visual Inspection Coating thickness control parameters Packaging Coating solution Page 33
31 Material Residence Time distribution Product Plug tracking Ingredients API Lot 1 Lot 2 Excipient 1 Lot 1 Lot 2 Excipient 2 Lot 1 Lot 2 Granulation Drying F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 F4C4 F4C5 Millling/Blending F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 F4C4 Compression F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 Coating F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 Time Output Drum 1 Drum 2 Drum 3 Page 34
32 Material Residence Time distribution Real Time Release floating window Ingredients API Lot 1 Lot 2 Excipient 1 Lot 1 Lot 2 Excipient 2 Lot 1 Lot 2 Granulation Drying Release window F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 F4C4 F4C5 Millling/Blending F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 F4C4 Compression F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 F4C3 Coating F1C1 F1C2 F1C3 F1C4 F1C5 F1C6 F2C1 F2C2 F2C3 F2C4 F2C5 F2C6 F3C1 F3C2 F3C3 F3C4 F3C5 F3C6 F4C1 F4C2 Time Output Drum 1 Drum 2 Drum 3 Page 35
33 SIPAT: data monitoring and control in real time Principle LIMS RTR SCADA Raw Material Characteristics + Context data Analytical Data Data alignment Contextualization Rules separating non-representative data Statistical Real Time Models e.g. PLS, PCA Chemometrics (SIMCA, Matlab, Unscrambler, PharmaMV, ) engine embedded in SIPAT CQA Critical to Qualty Attribute Aggregation of CQA over process context - Average, - Standard deviation On line Monitoring Out of control detection Deviation tracking NIR, PSD SIPAT APC Analyzer Page 36
34 Data Driven Manufacturing SiPAT allows to measure inline the CQA s, real time Increased number of measurements Test case of 50hrs material - Moisture measured 960 times - Particles size distribution measurements: 960 times - Content uniformity: 100 times - Tablet weight: each tablet (1,8 Mio) Enhanced product security Data correlation across units Page 37 37
35 Results of the trials Main findings of the feasibility study: Reduced process development time Page 38 Unlimited number of reference batches as a basis for model creation Real Time Release enabling Quality information available on tablet level rather than on batch level Increased process understanding Through Real Time Quality Assurance Time-based process: scalability improvement Savings in construction, space, energy, maintenance Increase of yield and equipment efficiency Reduction of scrap, waste & rework Reduction of raw material Reduction of human interference (cost, safety)
36 Article available on request Page 39
37 Better process understanding leads to a more efficient result! Page 40
38 Thank you for your attention! Jan Verelst Siemens Industrial IT
Continuous Manufacturing
Continuous Manufacturing Continuous ing in the Industry Continuous processing has been adopted by the majority of process industries for the manufacturing of fluids (i.e. liquids and gasses) and solids
More informationConsiderations for selecting an Advanced. System. Barbara Spangl-Kavsek, Siemens AG Katherine Bakeev, CAMO Software Inc.
Considerations for selecting an Advanced Process Optimization System Barbara Spangl-Kavsek, Siemens AG Katherine Bakeev, CAMO Software Inc. Agenda What is an advanced process optimization system? Aggregation
More informationPAT for the On-line Characterization of Continuous Manufacturing Systems
PAT for the On-line Characterization of Continuous Manufacturing Systems Thomas O Connor, Ph.D. Office of Pharmaceutical Science FDA/PQRI Conference: Innovation in Manufacturing and Regulatory Assessment
More informationNIRS, PAT, RTR testing EU experience and regulatory perspective
NIRS, PAT, RTR testing EU experience and regulatory perspective Heidelberg, Germany October 2013 European Compliance Academy (ECA) Overview of the presentation General considerations Cases submitted in
More informationRegulatory Assessment
Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal
More informationControl Strategy. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 Control Strategy International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Introduction Structure of this session
More informationPAT - Seen from an Automation and Information Solutions Provider
PAT - Seen from an Automation and Information Solutions Provider Alberto Rossi Rockwell Automation 09. October 2007 Copyright 2007 Rockwell Automation, Inc. All rights reserved. 1 Agenda 1. 1. Rockwell
More informationSuccessful Introduction of PAT Requires a Strategy
OR AL SOLID DOSAGE CONTINUOUS MANUFACTURING TECHNOLOGIE S Successful Introduction of PAT Requires a Strategy By Dr. Hubertus Rehbaum, Pharma/Life Sciences Consultant F Dr. Hubertus Rehbaum or the past
More informationImplementation of PAT for Real Time Release Testing. Mark Smith Process Analytical Sciences Group Pfizer, Cork
Implementation of PAT for Real Time Release Testing Mark Smith Process Analytical Sciences Group Pfizer, Cork PAT at Pfizer A key enabler for transformational strategies and new quality paradigms 9 Delivering
More informationPAT/QbD Bringing Pharma into the 21 st Century. Creating Innovations for the Pharmaceutical Industry. usa.siemens.com/pharma
PAT/QbD Bringing Pharma into the 21 st Century Creating Innovations for the Pharmaceutical Industry usa.siemens.com/pharma The pharmaceutical industry is headed for fundamental changes within the next
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More informationPAT for the On-line Characterization of Continuous Manufacturing Systems
PAT for the On-line Characterization of Continuous Manufacturing Systems Thomas O Connor, Ph.D. Office of Pharmaceutical Science FDA/PQRI Conference: Innovation in Manufacturing and Regulatory Assessment
More informationQuality by Design, Revolution or Evolution? Wim Oostra
Quality by Design, Revolution or Evolution? Wim Oostra 1993 1998 2007 2009 2013 And many more.. Content Introduction A bit of history Examples A New product Legacy product Today? The triggers The goal
More informationPAT Initiative Pilot Project API Production. Gerhard Korb. Sanofi-Aventis Deutschland GmbH. Process Development Chemistry
Gerhard Korb Sanofi-Aventis Deutschland GmbH Process Development Chemistry Chemical & Particle Engineering Frankfurt Summary PAT Initiative Pilot Project API Production Tools - Definition Example Additional
More informationEasy to use multivariate process monitoring solution for on-line or at-line applications
Bring data to life Easy to use multivariate process monitoring solution for on-line or at-line applications Predict and correct process deviations before they become problems Customizable, easy to set
More informationApplication of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013
Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for
More informationProcess Analyzer Continuous Verification
Process Analyzer Continuous Verification Jason E. Dickens, PhD Property of GlaxoSmithKline 2 PAT Cost-Complexity-Benefit Continuum Low End High End Simple Sensors Univariate Analyzers Spectral Analyzers
More informationAssociation. Case Study 3. achieving real time release testing by a
Case Study 3 Applying PDA: QbD for A a legacy Global product and achieving real time release testing by a design Association space approach with supportive PAT and soft sensor based models: Challenges
More informationPAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany
PAT in Action: A Lifecycle Approach to Applied Process Understanding to set meaningful process and product specifications October, Heidelberg, Germany ir Sander van den Ban, CEng The Unpredictability of
More informationConsiGma. A platform for Continuous Solid Dosage manufacturing enabling Quality by Design and Lean Manufacturing O. GOLDSTEIN
ConsiGma A platform for Continuous Solid Dosage manufacturing enabling Quality by Design and Lean Manufacturing O. GOLDSTEIN GRANULATION & AGGLOMERATION SEMINAR 25 TH OF OCTOBER 2016 Why Continuous Processing?
More informationImplementation of QBD for Analytical Methods - Session Introduction -
Implementation of QBD for Analytical Methods - Session Introduction - Sonja Sekulic January 24, 2014 Quality by Design (QbD) A Systematic Approach ICH Q8(R2) Product Profile Define quality target product
More informationPAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets. Part 1: Concept and Principles Part 2: Mock P2 Submission
PAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets Part 1: Concept and Principles Part 2: Mock P2 Submission 1 Part 1 Concept and Principles Introduction Rationale Concept
More informationApplied Process Understanding in Drug Product Development
Applied Process Understanding in Drug Product Development A combined pharmaceutical science, materials science and chemical process engineering approach 17 October, Heidelberg, Germany ir Sander van den
More informationApproval Application Form for Sakura Bloom Tablets
Approval Application Form for Sakura Bloom Tablets Mock-up for Columns of Manufacturing Methods and Specifications & Test Methods for Drug Products (sample description) Study project for regulatory harmonization
More informationTotal Containment Solutions
Total Containment Solutions Buck Systems Technologies GEA Pharma Systems GEA Pharma Systems is world leader in providing advanced processing solutions for solid dosage forms to the pharmaceutical industry.
More informationInnovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series
CAMO European Pharmaceutical Seminars Jan/Feb 2009 Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series The Increasing Need of Multivariate Analysis for Process Understanding
More informationIntegrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration
Integrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration Presented by: Mairtin Martin Mc Gadsby Namara (J&J) Martin Gadsby (Optimal) 1 Overview Introduction
More informationContinuous Manufacturing: An Industry View
Novartis Pharmaceuticals Continuous Manufacturing: An Industry View Diane Zezza Novartis Pharmaceuticals FDA/PQRI Conference on Advancing Product Quality March 22, 2017 Where are we today? Continuous Manufacturing
More informationProcess Automation. Process Analytical Technology Executive Summary for the Life Sciences Industry
Automation Analytical Technology Executive Summary for the Life Sciences Industry Why ABB? A Quality by Design (QbD) approach using Analytical Technology (PAT) requires more than a collection of analyzers
More informationBatch Statistical Process Control (BSPC): a powerful multi-level risk & process analytics tool
Batch Statistical Process Control (BSPC): a powerful multi-level risk & process analytics tool AgroStat 2016 March 21-24, 2016 Lausanne Sébastien Preys Ondalys France Consulting and Training in Chemometrics
More informationPharmaceutical Manufacturing Technology Centre
Pharmaceutical Manufacturing Technology Centre Research themes for Initial Research Programme Call for Proposals The Centre will focus on advanced pharmaceutical manufacturing technologies with an initial
More informationQuality by Design for Drug Products. Dr. Lorenz Liesum Global Technical Operation, Novartis Swiss Association for Quality Meeting , Olten
Quality by Design for Drug Products Dr. Lorenz Liesum Global Technical Operation, Novartis Swiss Association for Quality Meeting 04-03-2010, Olten Overview QbD/PAT Concept QbD/PAT Toolbox DoEs PAT Methods
More informationPQLI Engineering Controls and Automation Strategy
J Pharm Innov (2008) 3:88 94 DOI 10.1007/s12247-008-9031-5 PRODUCT QUALITY LIFECYCLE IMPLEMENTATION (PQLI) INNOVATIONS PQLI Engineering Controls and Automation Strategy Ray Bolton Stephen Tyler Published
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationPRODUCTION AND PERFORMANCE MANAGEMENT DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT IN THE REGULATED INDUSTRIES
PRODUCTION AND PERFORMANCE MANAGEMENT DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT IN THE REGULATED INDUSTRIES DATA HISTORIANS FOR INCIDENT AND DEVIATION MANAGEMENT DATA HISTORIANS FOR INCIDENT
More informationBetter wet granulation: development, scale-up and manufacture
Better wet granulation: development, scale-up and manufacture By Tim Freeman, Freeman Technology Wet granulation is a common unit operation in the pharmaceutical industry yet accurate endpoint detection
More informationContent PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2
EMA, FDA- ANDA Readiness -OSD Generics Solution Post Formulation Development Horch Guo, May. 2016, Changzhou, China Hongxing.guo@yahoo.com Content PART I: ANDA Roadmap PART II: Understanding of CPPs &
More informationProcess Analytical Technology (PAT) / Quality by Design (QbD): Integrated Systems in the Future Pharma Business Landscape
Process Analytical Technology (PAT) / Quality by Design (QbD): Integrated Systems in the Future Pharma Business Landscape Glenn Restivo Industry Manager Life Sciences Siemens Center of Competence Sept
More informationQbD implementation in Generic Industry: Overview and Case-Study
QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They
More informationManufacturing Technology Committee Risk Management Working Group Risk Management Case Studies. Case No. RMWG-07. Space
Manufacturing Technology Committee Risk Management Working Group Risk Management Case Studies Case Study Title: Defining Process Design Space Case No. RMWG-07 GMP System Impacted: Introduction / Background
More informationAgilent TRS100 Raman. Quantitative Pharmaceutical Analysis System
Agilent TRS100 Raman Quantitative Pharmaceutical Analysis System Agilent TRS100 Raman Streamlined Quality Control Fast Test hundreds of intact tablets or capsules in minutes Simple Quantify active pharmaceutical
More informationContinuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens.
Continuous manufacturing moving towards real-time release Creating innovations for the pharmaceutical industry siemens.com/pharma Strategic partnership Creative ideas and industry expertise A move to continuous
More informationAn integrated multi-layer approach to control strategy for continuous drug product manufacture
An integrated multi-layer approach to control strategy for continuous drug product manufacture Ahmad Almaya, Ph.D. Eli Lilly and Company February 2016 Lilly s Journey with DP CM 2010 Business Case 2011
More informationImplementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development. S Betterman 15Apr2015
Implementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development S Betterman 15Apr2015 Agenda Background Implementation Strategy Infrastructure Building Project Application
More informationTECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12
INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT Q12 ANNEX Draft
More informationCHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE
CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE Paul Stott, PhD Head of US Product Development AstraZeneca ICH Quality Guidelines Workshop BioKorea 2007 Sept 13-14
More informationSugar factory automation and optimization. Control. Visualize. Optimize.
Sugar factory automation and optimization Control. Visualize. Optimize. Lowering energy consumption Increasing throughput Improving quality Maximizing traceability Reducing inventory cost Enabling lean
More informationThe use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible?
The use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible? Limin Zhang (Bristol-Myers Squibb Company) Andre Hermans (Merck & Co., Inc.) 2017 M-CERSI Workshop
More informationCurrent Industry Practices in Manufacturing Process Validation. Russ Somma PhD
Russ Somma PhD The objectives for validation are: Demonstrate control over the process and finished product. Demonstrate that the process will consistently produce product which meets all specifications
More informationProviding insight into pharmaceutical formulations
Providing insight into pharmaceutical formulations Dr Steve Ward-Smith Pharmaceutical Industry The average cost of developing a drug is reported to be approx $500 million, but up to 70% of new chemical
More informationDeveloping Pharmaceutical Continuous Crystallization Processes - Knowledge & Gaps. Chris Price on behalf of the IMI team Product Development
Developing Pharmaceutical Continuous Crystallization Processes - Knowledge & Gaps Chris Price on behalf of the IMI team Product Development Context - Innovative Manufacturing Initiative Move from Batch,
More informationScientific and Regulatory challenges in Quality by Design (QbD) submissions
Health Santé Canada Canada Scientific and Regulatory challenges in Quality by Design (QbD) submissions Krishnan R. Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences TPD, Health Canada CVG, October 2007
More informationContinuous Processing. MODCOS for Continuous Oral Solid Dosage Production Textmasterformat in Mastervorlage eingeben
Continuous Processing MODCOS for Continuous Oral Solid Dosage Production 1 Why continuous production 2 Why Continuous Production? Saving manufacturing costs High productivity because of substantial time
More informationMES Middle Ages Evolution Space. Florian Seitz Werum Asia Support Centre
MES From Past to Present to Future 1 MES Middle Ages Evolution Space Florian Seitz Werum Asia Support Centre MES From Past to Present to Future 2 From Past to Present to Future Nokia 5100 iphone 5 15 years
More informationReal-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology
Real-Time Prediction of Polymer-Coated Multiparticulate Dissolution using Process Analytical Technology Authors: Piyush Patel A, Edward Godek B, Chris O Callaghan C, Dr. Ian Jones D A Colorcon, PA, USA
More informationDeltaV Distributed Control System October PAT and Batch Recipe Execution
DeltaV Distributed Control System White Paper October 2016 PAT and Batch Recipe Execution Table of Contents Introduction... 3 Data Transfers... 4 Recipe Development... 4 Recipe Execution... 5 Recipe Completion...
More informationISPE Annual Meeting 29 October 1 November 2017 San Diego, CA. FDA Perspective on the Use of Process Capability
FDA Perspective on the Use of Process Capability Chunsheng Cai, Ph.D. Office of Process and Facilities Office of Pharmaceutical Quality, CDER, FDA 2017 ISPE Annual Meeting & Expo Disclaimer This presentation
More informationQuality by Design (QbD)
Evaluating the Critical Quality attributes & Critical Process Parameters-A Case Study-Tablets GMP International Workshop February 20/21, 2008 Mumbai, India Mukund Yelvigi Director, Therapeutic Area Management,
More informationTaking mechanistic models from R&D and Engineering into Operations
Taking mechanistic models from R&D and Engineering into Operations Andy Mitchell (Perceptive Engineering) Niall Mitchell (Process Systems Enterprise) Introductions 2 Process Systems Enterprise Who we are:
More informationProduct Summary of XLReporter with GE Intelligent Platforms SyTech, Inc.
Product Summary of XLReporter with GE Intelligent Platforms SyTech, Inc. Page 1 Contents Summary... 3 SYTECH is THE REPORT COMPANY... 3 Product Overview... 4 XLREPORTER EDITIONS... 4 DATA INTERFACES...
More informationGENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES
July 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES REVISED
More informationICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management - Annexes
1 2 3 14 December 2017 EMA/CHMP/ICH/831751/2017 Committee for Medicinal Products for Human Use 4 5 6 7 ICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle
More informationFault tolerant control for safe plant operation. November 10, 2016
Real Time Release in Continuous Solid Dose Manufacturing: Systematic Characterization of Material Properties, and Optimal Design of Sensing and Control Methods Fault tolerant control for safe plant operation
More informationICH Q8/Q8(R)
Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since
More informationSuccessful Tableting Supplement. Continuous Tableting MODUL Q A-Type Tooling. engineering for a better world
Successful Tableting Supplement Continuous Tableting MODUL Q A-Type Tooling engineering for a better world Why GEA? Operational excellence For more than a hundred years, our innovation, driven by our passion
More informationNIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production
NIR Checkmaster Near-infrared spectroscopy On-line analysis of active ingredients during tablet production Slash release times with NIR Innovative features Fully automatic assay of tablet weight, hardness,
More informationAspen InfoPlus.21 Family
Aspen InfoPlus.21 Family The process industry s most comprehensive production management solution for unleashing innovation and creativity to improve profitability The Aspen InfoPlus.21 Family aggregates
More informationStage 3 - Process Validation: Measuring what matters
Stage 3 - Process Validation: Measuring what matters Trevor Schoerie - PharmOut A quote. The company that fails is the company that comes to us and says Just tell us what to do and we will do it. The company
More informationDiode Array In-line NIR sensor. Reliable, Accurate, Real-time Agri and Food Measurement
Diode Array 7300 In-line NIR sensor Continuous Measurement Automatic Process Control Reliable Industrial Design Web-based User Interface Reliable, Accurate, Real-time Agri and Food Measurement DA 7300
More informationCombining Laboratory and Process Data on the PI System. Copyright 2013 OSIsoft, LLC.
Combining Laboratory and Process Data on the PI System Presented by Kevin Crean Kevin Crean Automation and Control Engineer Manufacturing Systems - Janssen Pharmaceutical 2 Agenda Introduction Janssen
More informationThe new BioPAT MFCS 4
The new BioPAT MFCS 4 Developed for the Process Designed for You! turning science into solutions Page 1 Contents 1 Overview 2 3 4 Features & Highlights Good to know Outlook Page 2 Overview BioPAT MFCS
More informationOptimization of a Continuous Wet Granulation Process by Understanding Granule Properties
Optimization of a Continuous Wet Granulation Process by Understanding Granule Properties Presented By Andrew Birkmire Process Development Manager GEA Process Engineering Presentation Outline Description
More informationAvailable online at ScienceDirect. Procedia Engineering 102 (2015 )
Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 102 (2015 ) 443 449 The 7th World Congress on Particle Technology (WCPT7) A QbD approach to continuous tablet manufacture Tim
More informationPreventing Errors with a Mobile MES
AADECA JORNADA TECNICA MES* EN INDUSTRIA FARMACEUTICA 14/05/2010 *MANUFACTURING ENTERPRISE SYSTEMS ISPE Preventing Errors with a Mobile MES Agenda Manufacturing Challenges - MES Benefits MES Systems Purpose
More informationYang Angela Liu, Ph.D. Pfizer Worldwide Research & Development Groton CT, USA
On the horizon: The integrated PAT control strategy for PCMM (portable, continuous, miniature, modular) - an agile development and manufacturing platform Yang Angela Liu, Ph.D. Pfizer Worldwide Research
More informationDr Claire MacDonald Business Development Manager CMAC National Facility
Dr Claire MacDonald Business Development Manager CMAC National Facility This presentation will cover CMAC Overall Vision CMAC National Facility Capabilities and Expertise API Process Development Secondary
More informationT41 - Batch Management
T41 - Batch Management What s New and What s Next Agenda Batch and Sequencing Opportunities Modern Batch Differentiation Scalable Batch Solutions What s Next? 2 Batch and Sequencing Opportunities Distributed
More informationPolestar Power Industries (Pharma Division) Pioneer Manufacturer Of Beta-Lactum & Cephalosporin
Polestar Power Industries (Pharma Division) Pioneer Manufacturer Of Beta-Lactum & Cephalosporin R Polestar Power Industries (Pharma Division) Vill. Damuwala, Haripur Road, Barotiwala, Tehsi l Baddi, Distt.
More informationRoller Compaction: New trends, challenges and solutions
Roller Compaction: New trends, challenges and solutions TODD STUTZMAN, PHARM.D. R.PH. DIRECTOR, PHARMACEUTICS SARAH PYSZCZYNSKI, PH.D. PRINCIPAL SCIENTIST 21FEB2017 2017 Catalent Pharma Solutions. All
More informationNATOLI AIM SOFTWARE. for data acquisition, analysis, and control systems. natoli.com
NATOLI AIM SOFTWARE for data acquisition, analysis, and control systems natoli.com DATA ACQUISITION & ANALYTICAL AND OPERATING SYSTEM SOFTWARE FOR TABLET PRESS R&D, PRODUCTION, AND MORE Natoli AIM Software
More informationDigital Solutions for the Life Sciences Industry The connected product and manufacturing concept
Digital Solutions for the Life Sciences Industry The connected product and manufacturing concept Unrestricted Siemens AG 2017 Realize innovation. An introduction Andrew Whytock Vertical Pharma Competence
More informationSeamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production
Seamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production Abstract A study was conducted using the KOCO 25 in conjunction with the ROB 50, in order to provide insight
More informationInt. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries
Review Article Process Validation of Tablet Dosage Form in Industries Ram Mohan S.R, N. Vishal Gupta* Pharmaceutical Quality Assurance group, Dept of Pharmaceutics, JSS University, Sri ShivarathreeshwaraNagara,
More informationContainment Barrier Systems
Containment Barrier Systems As an international leader, focused on Quality, Telstar partners with clients to provide high value on a global basis through innovation, advanced technology, absolute reliability
More informationPharmaceutical control strategy what does it mean and how do we apply? Martin Warman, Martin Warman Consultancy Ltd
Pharmaceutical control strategy what does it mean and how do we apply? Martin Warman, Martin Warman Consultancy Ltd How can the words control strategy cause such debate? Means totally different things
More informationLearning from the Application of Real-Time Analytics for Process Understanding, Control and Real-Time Release Testing
Learning from the Application of Real-Time Analytics for Process Understanding, Control and Real-Time Release Testing Ruben Lozano, Douglas Both and Ambarish Singh Bristol-Myers Squibb Biopharmaceutics
More informationProficy * Plant Applications. GE Intelligent Platforms. Plant Performance Analysis and Execution Software
GE Intelligent Platforms Proficy * Plant Applications Plant Performance Analysis and Execution Software As a production manager, the key to unlocking the full performance potential of your manufacturing
More informationDigitalization in Pharma Howard Sachs, Business Segment Pharmaceuticals, Siemens. Unrestricted Siemens AG 2017
Digitalization in Pharma Howard Sachs, Business Segment Pharmaceuticals, Siemens Realize innovation. Page 1 changes everything MindSphere + Video Digitalization 2016 Page 2 Digitalization Changes Everything,
More informationPat Monitoring of Particles in API Manufacture and Formulation
Pat Monitoring of Particles in API Manufacture and Formulation By: Brian O Sullivan Ph.D PAT Seminar Singapore Sept 11 th 2007 brian.osullivan@mt.com What do these have in common? Space shuttle Lipitor
More informationPMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft)
PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft) March 30, 2018 Pharmaceuticals and Medical Devices Agency Innovative Manufacturing Technology
More informationConducting Supplier Audits: Ensure Validation Compliance
Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why
More informationQuality by Design and Expertise: Accelerating time to market of complex oral solid dosage forms
CPhI Worldwide 2017 October 24 th -v 26 th, 2017 Frankfurt Quality by Design and Expertise: Accelerating time to market of complex oral solid dosage forms Lucile KOWALSKI - NPI Project Manager Guy VERGNAULT
More informationCombining Laboratory and Process Data on the PI System. Copyri g h t 2013 OSIso f t, LLC.
Combining Laboratory and Process Data on the PI System Presented by Kevin Crean Kevin Crean Automation and Control Engineer Manufacturing Systems - Janssen Pharmaceutical 2 Agenda Introduction Janssen
More informationIndustry Perspective on Lifecycle Management
Industry Perspective on Lifecycle Management and Post-Approval Building Changes the Best title here Focus on Quality by Design FDA/PQRI Conference on Evolving Product Quality Sep. 16-17, 2014 Michael Kimball
More informationHow the European Pharmacopoeia Provides the Framework to Implement QbD Principles
How the European Pharmacopoeia Provides the Framework to Implement QbD Principles Dr Emmanuelle Charton Deputy Head, European Pharmacopoeia Department, EDQM, Council of Europe Structure of the Presentation
More informationBenefits. + + Consistent quality to recipe specification. + + Increase asset utilization and operational efficiency
Wonderware InBatch Flexible Batch Management Wonderware InBatch software enables sophisticated equipment arbitration and concurrent batch execution capabilities to maximize asset utilization, plant throughput
More informationInduSoft Web Studio Builds HMI/SCADA Applications Both Large and Small
Editorial contact: Marcia R. Gadbois VP of Business Development (512) 349-0334 mroland@indusoft.com www.indusoft.com BACKGROUND INFORMATION InduSoft Web Studio Builds HMI/SCADA Applications Both Large
More informationApplication to Drug Substance Crystallization Marino Nebuloni
Application to Drug Substance Crystallization Marino Nebuloni REDOX Monza Parma University Objectives of the presentation 1.Crystallization principles 2.What are QbD (Quality by Designe) and PAT (Process
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More informationClosing the loop of an industrial value chain with MindSphere IoT. Embedded Conference Finland
Closing the loop of an industrial value chain with MindSphere IoT Embedded Conference Finland 18.4.28 Restricted Siemens AG 28 mindsphere.io Siemens in brief Digitalization is a key driver of innovation
More information